Back to Results

21st North Inc (ULGX)

21st North Inc, trading on OTC Markets under the symbol ULGX, is a common stock listing associated with a healthcare company focused on minimally invasive treatments for benign prostatic hyperplasia (BPH). The business develops, manufactures, markets, and distributes medical products in the United States aimed at relieving urinary obstruction and related symptoms caused by BPH. Its product portfolio includes Cooled ThermoTherapy, which combines microwave energy with cooling technology to help protect surrounding tissue and improve patient comfort, and the Prostiva RF Therapy System, which uses radio frequency energy to target prostate tissue and reduce urethral constriction. The company serves patients and clinicians and was founded in 1991. It is based in Minneapolis, Minnesota.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-ULGX
Not available
Not available
Not available
Weak
0.0%
0.021 K
Valuation • Fair Value

21st North Inc (OTC-ULGX) Fair Value by Valuation Model

No usable valuation estimate is currently available for 21st North Inc (OTC-ULGX); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for 21st North Inc (OTC-ULGX). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for 21st North Inc (OTC-ULGX)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review 21st North Inc (OTC-ULGX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for 21st North Inc (OTC-ULGX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for 21st North Inc (OTC-ULGX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for 21st North Inc (OTC-ULGX)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for 21st North Inc (OTC-ULGX). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for 21st North Inc (OTC-ULGX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for 21st North Inc (OTC-ULGX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for 21st North Inc (OTC-ULGX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for 21st North Inc (OTC-ULGX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for 21st North Inc (OTC-ULGX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

21st North Inc (OTC-ULGX) Stock FAQ

Data-supported answers about 21st North Inc (OTC-ULGX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for 21st North Inc (OTC-ULGX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for 21st North Inc (OTC-ULGX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for 21st North Inc (OTC-ULGX).

The current market capitalization listed for 21st North Inc is 0.021 K.

The ticker symbol for 21st North Inc is OTC-ULGX, and the stock is listed on OTC Markets.

21st North Inc (OTC-ULGX) is listed on OTC Markets.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 156.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 117.8 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.8 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 66.215 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 54.18 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.34 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.818 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 44.147 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 35.562 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 33.943 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 32.273 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 29.411 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 26.348 B
STE NYSE STERIS plc Fair Value Fair Market Cap 22.635 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 18.799 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.539 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.08 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 12.906 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.778 B